Interestingly, our report (31) demonstrated that anticancer drugs, such as cisplatin and paclitaxel, preferentially induce COL11A1 expression in the cisplatin-resistant ovarian cancer cell line A2780CP70, but not in its cisplatin-sensitive counterpart, the A2780 cell line. The gene discussed is COL11A1; the disease is ovarian cancer.